Ausnutria Dairy Corp. Ltd. (1717) AI Stock Analysis

• Market Cap: HK$3.47B
• Dividend Yield: 2.56%
• Average Volume (3M): 164.48K
• Price to Earnings (P/E): 13.6
• Beta (1Y): 0.65
• Revenue Growth: -1.56%
• EPS Growth: 30.87%
• Country: HK
• Employees: 3,288
• Sector: Consumer Defensive
• Sector Strength: 64
• Industry: Packaged Foods
• EPS (TTM): 0.06
• Shares Outstanding: 1,778,144,900
• 10 Day Avg. Volume: 262,348
• 30 Day Avg. Volume: 164,478
• PEG Ratio: -1.24
• Price to Book (P/B): 0.57
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 8.36
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 66 Neutral
• Price Target: HK$2.00 ▲(2.04%Upside)

The overall stock score of 66 reflects a stable financial position with a strong equity base and moderate valuation. However, the company faces challenges in cash flow management and lacks strong growth momentum, as indicated by flat revenue growth and neutral technical indicators. The absence of earnings call data and corporate events limits additional insights.

Ausnutria Dairy Corp. Ltd. Business Overview & Revenue Model

Company Description

Ausnutria Dairy Corporation Ltd, an investment holding company, primarily engages in the research and development, milk collection, processing, production, packaging, marketing, and distribution of infant formula and other dairy products. The company operates in two segments, Dairy and Related Products, and Nutrition Products. It offers cow milk-based formula products under the Allnutria, Hyproca Hollary, Hyproca Hypure, Neolac, and Puredo brand names; and goat milk-based infant formula products under the Kabrita brand. The company also produces formula milk powder products on an original equipment manufacturing basis. In addition, it engages in the manufacturing and distribution of nutrition products; development, distribution, and sale of probiotic products; and provision of financing services. The company operates in the People's Republic of China, the European Union, Southeast Asia, Australia, New Zealand, the Middle East, North and South America, and internationally. The company was founded in 2003 and is based in Sheung Wan, Hong Kong. Ausnutria Dairy Corporation Ltd operates as a subsidiary of HongKong Jingang Trade Holding Company Limited.

How the Company Makes Money

Ausnutria Dairy Corp. Ltd. generates revenue primarily through the sale of its dairy-based products, with a significant focus on infant formula. The company offers a diverse portfolio of products under various brand names, catering to different market segments and consumer preferences. Key revenue streams include the sale of cow milk-based and goat milk-based infant formulas, which are distributed through a network of retail and online channels. Ausnutria invests in research and development to differentiate its products, enhancing their nutritional content and market appeal. Additionally, the company benefits from strategic partnerships and collaborations with research institutions and other companies in the dairy sector, which contribute to its product innovation and market expansion efforts.

Ausnutria Dairy Corp. Ltd. Financial Statement Overview

Summary

Ausnutria Dairy Corp. Ltd. demonstrates a stable financial position with strong equity but faces challenges in cash flow management. Profitability and margin improvements are noteworthy, but growth has been flat, indicating a need for strategic initiatives. The balance sheet is robust, though liquidity needs attention due to declining cash reserves. Overall, the company is well-positioned but should focus on enhancing operational efficiency and cash flow management to sustain future growth.

Income Statement

The company has shown consistent revenue generation with a slight increase in 2024 compared to previous years. Gross Profit Margin remained strong at 41.98% in 2024, reflecting a good cost management strategy. Net Profit Margin improved to 3.19% in 2024 from 2.36% in 2023, indicating enhanced profitability. However, EBIT Margin and EBITDA Margin are relatively low at 5.16% and 8.71% respectively, suggesting operational efficiency could be improved. The revenue growth has been stagnant, indicating a need for strategic growth initiatives.

Balance Sheet

The balance sheet shows a stable position with a Debt-to-Equity Ratio of 0.39, suggesting conservative leverage. Return on Equity (ROE) is relatively low at 4.12% in 2024, indicating modest returns to shareholders. The Equity Ratio remains strong at 59.23%, highlighting a solid capital structure with a significant proportion of assets financed by equity. The company has maintained a healthy cash reserve, although there is a slight decline in cash and cash equivalents over the years, which might restrict liquidity.

Cash Flow

The cash flow position is mixed, with Operating Cash Flow to Net Income Ratio of 1.27 in 2024, indicating good cash conversion. However, Free Cash Flow has been negative, reflecting high capital expenditures that have not been matched by operational inflows, potentially affecting long-term cash sustainability. The Free Cash Flow to Net Income Ratio is negative, signaling concerns over cash efficiency and capital expenditure management.

Breakdown
TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
7.55B	7.40B	7.38B	7.80B	8.87B	7.99B
	Gross Profit
2.98B	3.11B	2.85B	3.39B	4.47B	3.98B
	EBIT
247.31M	381.71M	281.68M	274.67M	1.25B	1.25B
	EBITDA
493.76M	645.26M	503.39M	529.50M	1.19B	1.50B
	Net Income Common Stockholders
135.18M	235.97M	174.39M	216.53M	1.04B	1.00B
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
546.53M	1.42B	2.04B	1.87B	2.26B	1.86B
	Total Assets
3.92B	9.66B	10.03B	9.80B	9.51B	9.25B
	Total Debt
1.21B	2.25B	2.42B	1.56B	1.30B	1.09B
	Net Debt
764.35M	1.04B	378.00M	-301.42M	-959.17M	-771.24M
	Total Liabilities
2.33B	3.88B	4.28B	4.23B	4.02B	4.10B
	Stockholders Equity
1.47B	5.72B	5.69B	5.65B	5.54B	5.17B
Cash Flow		Free Cash Flow
388.13M	-86.32M	-459.31M	-1.06B	514.93M	623.59M
	Operating Cash Flow
824.10M	299.37M	224.71M	-357.54M	1.07B	1.13B
	Investing Cash Flow
-508.94M	-899.16M	-740.92M	-723.98M	-606.57M	-402.58M
	Financing Cash Flow
-190.10M	-273.59M	682.45M	664.11M	-34.09M	-494.87M

Ausnutria Dairy Corp. Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1.96
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1717, the sentiment is Positive. The current price of 1.96 is above the 20-day moving average (MA) of 1.90, above the 50-day MA of 1.93, and above the 200-day MA of 1.93, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 58.25 is Neutral, neither overbought nor oversold. The STOCH value of 57.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1717.

Ausnutria Dairy Corp. Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
1717	66 Neutral	HK$3.47B	13.57	4.14%	2.56%	-1.56%	30.87%
Sector *	65 Neutral	$8.88B	15.01	4.76%	203.76%	3.54%	-2.49%
BTSDF		$1.01B	20.91	-0.91%	3.84%	―	―
CIADF		$9.05B	621.62	0.21%	2.98%	―	―
6186		HK$53.53B	13.81	14.06%	5.42%	―	―
0670	54 Neutral	HK$88.96B	―	-9.88%	―	14.25%	―

Ausnutria Dairy Corp. Ltd. Corporate Events

Ausnutria Dairy Approves Dividend and Re-elects Directors at AGM

Ausnutria Dairy Corporation Ltd. announced the successful passage of all resolutions during its Annual General Meeting held on May 29, 2025. Key resolutions included the approval of a final dividend of HK$0.06 per share for the year ending December 31, 2024, and the re-election of several directors. The company’s strong shareholder participation, with over 84% of issued shares represented, underscores robust investor confidence. This development is likely to positively impact the company’s financial health and reinforce its market position.

Ausnutria Dairy Corp. Ltd. Announces 2025 AGM and Key Resolutions

Ausnutria Dairy Corp. Ltd. has announced its upcoming annual general meeting (AGM) scheduled for May 29, 2025, in Changsha City, China. Key agenda items include the re-election of several directors, approval of a final dividend of HK$0.06 per share, and the re-appointment of PricewaterhouseCoopers as auditors. Additionally, a general mandate for the directors to allot, issue, and dispose of shares is proposed. These resolutions aim to strengthen the company’s governance and financial strategies, potentially impacting shareholder value and market positioning.

Ausnutria Dairy Announces Final Cash Dividend for 2024

Ausnutria Dairy Corporation Ltd has announced a final ordinary cash dividend of HKD 0.06 per share for the financial year ending December 31, 2024. This announcement reflects the company’s financial performance and commitment to returning value to its shareholders, with the dividend payment scheduled for June 25, 2025.

Ausnutria Dairy Reports Strong Financial Performance for 2024

Ausnutria Dairy Corporation Ltd announced its financial results for the year ending December 31, 2024, reporting a slight increase in revenue by 0.3% to RMB 7,402.4 million. The company saw significant improvements in profitability, with gross profit rising by 8.9% and EBITDA increasing by 28.1%. Profit attributable to equity holders grew by 35.3%, and the company declared a final dividend of HK$0.06 per share, reflecting a 20% increase from the previous year. These results indicate a strong financial performance, suggesting enhanced operational efficiency and a positive outlook for stakeholders.

Ausnutria Dairy Faces Trading Suspension Amid Results Delay

Ausnutria Dairy Corporation Ltd has announced a delay in the publication of its 2024 Annual Results, leading to a continued suspension of trading in its shares on the Hong Kong Stock Exchange. The Board meeting is scheduled for April 10, 2025, to consider and approve the annual results and discuss the potential recommendation of a final dividend, impacting stakeholders with the uncertainty surrounding the company’s financial disclosures.

Ausnutria Dairy Delays Annual Results and Suspends Trading

Ausnutria Dairy Corporation Ltd has announced a delay in the publication of its annual results for the year ended December 31, 2024, due to the need for additional time to complete the annual audit process. This delay has led to the postponement of the board meeting and the suspension of trading in the company’s shares on the Hong Kong Stock Exchange. The company expects to publish the results by April 17, 2025, and assures there are no material disputes with auditors. Stakeholders are advised to exercise caution in dealing with the company’s securities.

Ausnutria Dairy Corp. Schedules Board Meeting to Discuss Annual Results and Dividend

Ausnutria Dairy Corporation Ltd has announced that its Board of Directors will hold a meeting on March 31, 2025. The meeting will address the approval of the company’s annual results for the year ending December 31, 2024, and consider the recommendation of a final dividend, which could impact shareholder returns and market perception.